v1
Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl4-induced liver fibrosis: Emphasis on gal-1/NRP-1/TGF-β and gal-1/NRP-1/VEGFR2 pathways
Identifier:nobleid.org/w1/20260421/477F9F31
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260421/477F9F31)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →